--Murphy Oil Maintains Quarterly Dividend at $0.30 Per Share, Payable June 3 to Holders of Record on May 20-February 2024-www.financetom.com

--Murphy Oil Maintains Quarterly Dividend at $0.30 Per Share, Payable June 3 to Holders of Record on May 20

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Murphy Oil Maintains Quarterly Dividend at $0.30 Per Share, Payable June 3 to Holders of Record on May 20

Apr 3, 2024 11:51 AM

02:23 PM EDT, 04/03/2024 (MT Newswires) --

Price: 47.90, Change: +0.96, Percent Change: +2.05

Previous page： Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing Next page： BioAge targets to raise up to $142.5 mln in US IPO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Vaxcyte Insider Sold Shares Worth $1,159,635, According to a Recent SEC Filing

Sep 22, 2024

04:28 PM EDT, 09/18/2024 (MT Newswires) -- Jim Wassil, COO, on September 16, 2024, sold 10,000 shares in Vaxcyte ( PCVX ) for $1,159,635. Following the Form 4 filing with the SEC, Wassil has control over a total of 200,646 shares of the company, with 200,646 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909424000068/xslF345X05/wk-form4_1726691002.xml ...

BioAge targets to raise up to $142.5 mln in US IPO

Sep 22, 2024

Sept 18 (Reuters) - BioAge Labs said on Wednesday it was aiming to raise as much as $142.5 million in its initial public offering in the United States. ...

Tesla Shares Surge Amid Fed Rate Cut And Cybertruck Developments

Sep 22, 2024

Tesla Inc. ( TSLA ) shares are trading higher Wednesday likely due to the broader market reaction to the Federal Reserve’s recent policy decision to cut interest rates by 50 basis points, marking the first rate cut in over four years. Federal Reserve Update The cutting of the federal funds rate to a range of 4.75%–5% has resonated across multiple...

Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B

Sep 22, 2024

Organon & Co ( OGN ) has agreed to acquire Roivant Sciences Ltd’s Dermavant Sciences Ltd, which is focused on developing and commercializing therapeutics in immunodermatology. Dermavant’s novel product, Vtama (tapinarof) cream, 1%, for the topical treatment of mild, moderate, and severe plaque psoriasis in adults, was approved by the FDA in May 2022. Vtama cream is a once-daily, steroid-free, topical...